Its blockbuster cystic fibrosis treatment costs $300,000 a year. Now Vertex wants to solve the opioid crisis
Published
With revenues having more than doubled since 2019, to $10bn, US pharma group targets painkillers
Full ArticlePublished
With revenues having more than doubled since 2019, to $10bn, US pharma group targets painkillers
Full Article